BBIO financial statements

The full income statement, balance sheet, and cash-flow statement for BridgeBio Pharma Inc. (BBIO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 188.0M2024-09 189.0M2024-12 190.2M2025-03 189.9M2025-06 191.2M2025-09 192.7M2025-12 193.9M2026-03 195.9M2026-06 195.5M+4.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	502M YoY+126.3%	222M YoY+2285.3%	9.30M YoY-88.0%	77.6M YoY+11.4%	69.7M YoY+745.1%
Cost of revenue	21.0M YoY+440.5%	3.88M YoY+58.5%	2.45M YoY-28.8%	3.43M YoY+10.3%	3.11M
Research & development	452M YoY-10.8%	506M YoY+11.1%	456M YoY+14.1%	399M YoY-11.4%	451M YoY+33.8%
Selling, general & administrative	531M YoY+83.9%	289M YoY+91.9%	151M YoY+5.2%	143M YoY-25.5%	192M YoY+31.9%
Restructuring	—	15.6M YoY+96.9%	7.93M YoY-81.9%	43.8M	0.00
Amortization of intangibles	2.70M YoY+12.5%	2.40M YoY+0.0%	2.40M YoY+0.0%	2.40M YoY-7.7%	2.60M
Operating income	-523M YoY+11.7%	-593M YoY+2.4%	-607M YoY-18.6%	-512M YoY+11.2%	-577M YoY-21.5%
Interest expense	53.1M YoY-41.6%	91.0M YoY+11.9%	81.3M YoY+1.1%	80.4M YoY+72.0%	46.8M YoY+27.6%
Interest & investment income	19.9M YoY+15.1%	17.2M YoY-4.4%	18.0M YoY+139.2%	7.54M YoY+565.7%	1.13M YoY-71.8%
Other non-operating income	43.1M YoY+250.9%	12.3M YoY-29.3%	17.4M YoY+331.6%	-7.50M YoY-120.9%	35.8M YoY+2092.4%
Equity-method income	-72.6M YoY-132.8%	-31.2M	0.00	0.00	—
Gain (loss) on equity securities	0.00 YoY-100.0%	8.14M YoY-55.6%	18.3M YoY+322.7%	-8.22M YoY-127.5%	29.9M
Pre-tax income	-733M YoY-35.1%	-542M YoY+17.0%	-653M YoY-34.8%	-485M	—
Income tax	435K YoY-62.3%	1.15M	0.00	0.00	—
	-733M YoY-34.9%	-543M YoY+16.8%	-653M YoY-34.8%	-485M YoY+17.4%	-586M YoY-16.0%
Net income to non-controlling interest	-8.01M YoY-5.6%	-7.58M YoY+24.5%	-10.0M YoY-189.7%	-3.47M YoY+85.5%	-23.9M YoY+57.9%
Net income to common	-725M YoY-35.3%	-536M YoY+16.7%	-643M YoY-33.7%	-481M YoY+14.5%	-563M YoY-25.4%
	-$3.78 YoY-31.3%	-$2.88 YoY+27.1%	-$3.95 YoY-21.2%	-$3.26 YoY+16.4%	-$3.90 YoY-2.6%
EPS (basic)	-$3.78 YoY-31.3%	-$2.88 YoY+27.1%	-$3.95 YoY-21.2%	-$3.26 YoY+16.4%	-$3.90 YoY-2.6%
	192M YoY+2.9%	186M YoY+14.3%	163M YoY+10.4%	147M YoY+2.2%	144M YoY+22.3%
	192M YoY+2.9%	186M YoY+14.3%	163M YoY+10.4%	147M YoY+2.2%	144M YoY+22.3%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	798M YoY+10.7%	721M YoY+50.9%	478M YoY-13.0%	549M YoY-38.3%	889M YoY+38.3%
Cash & equivalents	570M YoY-16.3%	681M YoY+81.2%	376M YoY-0.2%	377M YoY-4.3%	394M YoY+10.6%
Short-term investments	—	0.00	0.00 YoY-100.0%	51.6M YoY-86.9%	394M YoY+56.9%
Accounts receivable	139M YoY+2853.1%	4.72M YoY+169.7%	1.75M	—	—
Inventory	26.8M	0.00	—	—	—
Prepaid expenses	44.1M YoY+26.4%	34.9M YoY+43.5%	24.3M YoY+10.9%	21.9M YoY-32.1%	32.3M YoY-9.7%
	936M YoY+1.8%	919M YoY+68.3%	546M YoY-12.3%	623M YoY-38.5%	1.01B YoY+43.9%
Property, plant & equipment	5.37M YoY-23.5%	7.01M YoY-40.7%	11.8M YoY-18.9%	14.6M YoY-51.5%	30.1M YoY+47.9%
Operating lease right-of-use	8.15M YoY+41.3%	5.77M YoY-28.2%	8.03M YoY-24.8%	10.7M YoY-32.9%	15.9M YoY-3.6%
Intangible assets	28.1M YoY+17.3%	23.9M YoY-9.1%	26.3M YoY-8.3%	28.7M YoY-36.1%	44.9M
Other non-current assets	16.7M YoY-8.2%	18.2M YoY-19.6%	22.6M YoY+11.9%	20.2M YoY-38.8%	33.0M YoY+38.0%
	288M YoY+86.5%	154M YoY+7.3%	144M YoY+18.5%	121M YoY-10.1%	135M YoY+41.2%
Accounts payable	36.2M YoY+276.7%	9.62M YoY-9.7%	10.7M YoY-7.8%	11.6M YoY-2.7%	11.9M YoY+32.9%
Deferred revenue	7.19M YoY-50.8%	14.6M YoY+139.6%	6.10M YoY-25.3%	8.16M	0.00
Current lease liability	6.19M YoY+37.4%	4.51M YoY+9.2%	4.13M YoY+12.3%	3.67M YoY-25.6%	4.94M YoY+30.1%
Other current liabilities	120M YoY+263.5%	33.1M	—	—	—
Finance lease liability (current)	—	—	—	—	295K YoY+130.5%
	3.01B YoY+26.7%	2.38B YoY+25.8%	1.89B YoY+1.1%	1.87B YoY-0.6%	1.88B YoY+215.3%
Long-term debt	2.01B YoY+359.0%	437M YoY-2.0%	446M YoY+3.6%	431M YoY+0.1%	431M YoY+366.1%
Deferred revenue (non-current)	13.1M YoY-23.5%	17.1M YoY+358.7%	3.73M	—	—
Non-current lease liability	3.81M YoY-18.8%	4.70M YoY-47.7%	8.98M YoY-26.8%	12.3M YoY-29.6%	17.4M YoY+18.7%
Operating lease liability (total)	10.0M YoY+8.7%	9.20M YoY-29.8%	13.1M YoY-17.8%	15.9M YoY-28.7%	22.4M YoY+21.1%
Finance lease liability (total)	—	—	—	—	1.54M YoY-9.5%
Finance lease liability	—	—	—	—	1.25M YoY-20.9%
Other non-current liabilities	244K YoY-14.7%	286K YoY-94.9%	5.63M YoY-78.9%	26.6M YoY+20.7%	22.1M YoY+131.8%
	-2.09B YoY-42.1%	-1.47B YoY-8.4%	-1.35B YoY-7.9%	-1.25B YoY-44.1%	-870M YoY-1603.1%
Preferred stock	0.00	0.00	—	—	—
Common stock	202K YoY+3.1%	196K YoY+8.3%	181K YoY+15.3%	157K YoY+1.9%	154K YoY+23.2%
Additional paid-in capital	2.06B YoY+8.1%	1.90B YoY+28.5%	1.48B YoY+57.8%	939M YoY+11.5%	842M YoY-17.6%
Retained earnings	-3.82B YoY-23.4%	-3.10B YoY-20.9%	-2.56B YoY-33.5%	-1.92B YoY-33.5%	-1.44B YoY-61.7%
Treasury stock	323M YoY+17.6%	275M YoY+0.0%	275M YoY+0.0%	275M YoY+0.0%	275M YoY+266.7%
Accumulated other comprehensive income	12.0K YoY+50.0%	8.00K YoY-74.2%	31.0K YoY+109.5%	-328K YoY-148.5%	-132K YoY-168.8%
Non-controlling interest	10.6M YoY+4.4%	10.2M YoY-9.7%	11.2M YoY-0.3%	11.3M YoY+230.7%	3.41M YoY-92.9%
Total equity incl. non-controlling	-2.08B YoY-42.4%	-1.46B YoY-8.5%	-1.34B YoY-8.0%	-1.24B YoY-43.4%	-867M YoY-916.0%
Total liabilities & equity	936M YoY+1.8%	919M YoY+68.3%	546M YoY-12.3%	623M YoY-38.5%	1.01B YoY+43.9%
	202M YoY+3.1%	196M YoY+8.3%	181M YoY+15.6%	157M YoY+2.1%	154M YoY+22.6%
	195M YoY+2.5%	190M YoY+8.5%	175M YoY+16.2%	151M YoY+2.2%	147M YoY+19.9%
	194M YoY+1.9%	190M YoY+8.2%	176M YoY+16.2%	151M YoY+2.6%	148M YoY-0.9%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	-446M YoY+14.4%	-521M YoY+1.3%	-528M YoY-25.8%	-419M YoY+15.8%	-498M YoY-24.6%
Depreciation & amortization	5.43M YoY-10.6%	6.08M YoY-6.5%	6.49M YoY-4.1%	6.77M YoY+15.9%	5.84M YoY+301.3%
Intangible amortization	2.70M YoY+12.5%	2.40M YoY+0.0%	2.40M YoY+0.0%	2.40M YoY-7.7%	2.60M
Share-based compensation	133M YoY+38.9%	95.8M YoY-11.9%	109M YoY+18.7%	91.6M YoY-8.0%	99.5M YoY+70.2%
Deferred income taxes	0.00	0.00	0.00	—	—
Change in receivables	135M YoY+4434.6%	2.97M YoY+119.4%	-15.3M YoY-1.0%	-15.2M	—
Change in inventory	25.3M	0.00	0.00	—	—
Change in payables	26.6M YoY+1659.9%	1.51M YoY-45.6%	2.78M YoY+896.6%	-349K YoY-112.3%	2.83M YoY+485.4%
	-24.5M YoY-140.3%	60.8M YoY+12.5%	54.0M YoY-88.1%	453M YoY+325.6%	-201M YoY-279.0%
Capital expenditure	1.10M YoY+17.6%	933K YoY-28.6%	1.31M YoY-72.9%	4.82M YoY-63.6%	13.2M YoY+76.2%
Free cash flow	-447M YoY+14.3%	-522M YoY+1.4%	-529M YoY-24.7%	-424M YoY+17.0%	-511M YoY-25.5%
Acquisitions	0.00	0.00	0.00	0.00	0.00
Other investing activities	—	—	—	0.00	0.00 YoY-100.0%
	359M YoY-52.0%	748M YoY+65.8%	452M YoY+3537.9%	-13.1M YoY-101.8%	736M YoY+64.7%
Long-term debt issued	0.00 YoY-100.0%	450M	0.00	0.00 YoY-100.0%	456M
Long-term debt repaid	0.00 YoY-100.0%	473M	0.00 YoY-100.0%	20.5M YoY-83.5%	124M
Common stock issued	0.00 YoY-100.0%	315M YoY-30.0%	450M YoY+9170.6%	4.85M	0.00
Common stock repurchased	48.3M	0.00	0.00	0.00 YoY-100.0%	200M YoY+166.7%
Dividends paid	0.00	0.00	0.00	0.00	0.00
Other financing activities	—	0.00	0.00 YoY-100.0%	837K	0.00
Net change in cash	-111M YoY-138.5%	289M YoY+1402.4%	-22.2M YoY-208.0%	20.5M YoY-45.6%	37.7M YoY+783.0%
Interest paid	43.7M YoY-52.2%	91.3M YoY+49.5%	61.1M YoY+12.2%	54.4M YoY+82.9%	29.8M YoY+94.3%
Income taxes paid	1.20M	0.00	0.00	—	—
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	14.8B YoY+184.1%	5.22B YoY-25.7%	7.02B YoY+516.6%	1.14B YoY-53.7%	2.46B YoY-76.8%
P/S	29.5× YoY+25.6%	23.5× YoY-96.8%	744.9× YoY+5698.4%	12.8× YoY-63.6%	35.3× YoY-97.2%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: BBIO's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BBIO filings on SEC EDGAR → Not investment advice.